We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
IES Holdings
IESC
$15.2B
| $644K | ﹤0.01% |
12,771
-430
| -3% | -$20.7K |
|
|
VBIV
2377
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $644K | ﹤0.01% |
6,904
-247
| -3% | -$25K |
|
|
VRAY
2378
DELISTED
ViewRay, Inc.
VRAY
| $641K | ﹤0.01% |
147,251
-5,685
| -4% | -$27.6K |
|
2379
Applied Optoelectronics
AAOI
$11.5B
| $640K | ﹤0.01% |
76,577
+5,434
| +8% | +$54.6K |
|
|
HTB
2380
HomeTrust Bancshares
HTB
$848M
| $640K | ﹤0.01% |
26,294
-1,295
| -5% | -$29.3K |
|
2381
Hingham Institution for Saving
HIFS
$663M
| $639K | ﹤0.01% |
2,251
-73
| -3% | -$18.3K |
|
2382
OrthoPediatrics
KIDS
$595M
| $638K | ﹤0.01% |
13,078
-1,045
| -7% | -$50.2K |
|
2383
Equity Bancshares
EQBK
$1.05B
| $635K | ﹤0.01% |
23,157
-1,345
| -5% | -$34.3K |
|
|
ITOS
2384
DELISTED
iTeos Therapeutics
ITOS
| $635K | ﹤0.01% |
18,566
+8,039
| +76% | +$291K |
|
2385
Business First Bancshares
BFST
$1.03B
| $633K | ﹤0.01% |
26,449
-810
| -3% | -$18K |
|
2386
Turning Point Brands
TPB
$1.74B
| $633K | ﹤0.01% |
12,125
-949
| -7% | -$47.3K |
|
2387
Lands' End
LE
$403M
| $632K | ﹤0.01% |
25,478
-1,090
| -4% | -$32K |
|
2388
Sierra Bancorp
BSRR
$525M
| $631K | ﹤0.01% |
23,534
-800
| -3% | -$20.1K |
|
2389
Personalis
PSNL
$1.51B
| $629K | ﹤0.01% |
25,554
+818
| +3% | +$28K |
|
2390
American Outdoor Brands
AOUT
$157M
| $625K | ﹤0.01% |
24,812
-1,177
| -5% | -$25.3K |
|
2391
Precigen
PGEN
$2.59B
| $618K | ﹤0.01% |
89,761
-6,675
| -7% | -$56.4K |
|
2392
Clarus
CLAR
$143M
| $614K | ﹤0.01% |
36,013
-1,490
| -4% | -$25.3K |
|
2393
Old Second Bancorp
OSBC
$1.29B
| $614K | ﹤0.01% |
46,498
-2,080
| -4% | -$24.5K |
|
2394
Rafael Holdings
RFL
$107M
| $614K | ﹤0.01% |
15,589
-239
| -2% | -$7.75K |
|
2395
Acacia Research
ACTG
$470M
| $613K | ﹤0.01% |
92,108
-3,790
| -4% | -$23.9K |
|
2396
Anterix
ATEX
$1.94B
| $613K | ﹤0.01% |
12,998
-800
| -6% | -$32.9K |
|
2397
West Bancorporation
WTBA
$485M
| $611K | ﹤0.01% |
25,374
-820
| -3% | -$18.7K |
|
|
RBNC
2398
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $609K | ﹤0.01% |
21,201
-1,165
| -5% | -$26.7K |
|
2399
Tejon Ranch
TRC
$451M
| $607K | ﹤0.01% |
36,263
-1,460
| -4% | -$24.1K |
|
2400
JFrog
FROG
$10.8B
| $604K | ﹤0.01% |
13,613
+3,915
| +40% | +$226K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.